Castration Resistant Prostatic Neoplasms Recruiting Phase 1 / 2 Trials for Olaparib (DB09074)

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

IndicationStatusPhase
DBCOND0129140 (Castration Resistant Prostatic Neoplasms)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05252390NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTreatment